| Samuel Breit Research Group |
|
The intracellular chloride ion channel CLIC1. Current Research Projects
Opportunities for PhD and other higher degree research students Additional top-up funding is also often available for PhD students that already have a basic level of funding from Universities or other funding bodies. For enquiries, please see contact information, below.
Publications PubMed publications for Professor Breit External Funding Agencies Licensed discoveries Measurement of serum levels of MIC-1/GDF15 for prognosis and management of cardiovascular diseases has been licensed to Hoffman La Roche.
MIC-1/GDF15 for treatment of obesity and chronic inflammatory diseases has been licensed to Novo Nordisk AG. Licensing opportunities Measurement of serum levels of MIC-1/GDF15 for prognosis and management of cancer.
Current Laboratory Members Postdoctoral Fellows Research Assistants Graduate students Administrative support Contact Information
|
| Last Updated on Monday, 19 September 2011 12:19 |
As well as Research Program Head at St Vincent’s Centre of Applied Medical Research, Sam Breit is a Clinical Immunologist and Immunopathologist at St Vincent’s Hospital, Sydney and Professor of Medicine at University of New South Wales. The research activities of his Group are centred around the biology, role in disease pathogenesis and clinical application of two molecules that were first cloned and characterised by his laboratory in the 1990’s, on the basis of their increased expression with macrophage activation: